Eplerenone

8 trials 4 recruiting CCardiology

Filter these 8 trials by condition, phase, country and more.

Open in Search →

8 Registered trials

4 Recruiting

2 Completed trials

6 Sponsors

6 Countries

Phase III

Phase III/IV

Phase IV

Phase III: 3 Phase III/IV: 1 Phase IV: 4

Indications tested

Renal transplant 2

Sponsors using this IMP

CHRU De Nancy 3 Bispebjerg Hospital 1 Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia 1 Institute For Study Research Education And Therapy Of Vascular Heart Brain And Kidney Nosologies 1 Narodowy Instytut Kardiologii Stefana Kardynala Wyszynskiego Panstwowy Instytut Badawczy 1 Policlinico San Donato S.p.A. 1

All trials

8 total

Randomized controlled trial evaluating the impact of mineralocorticoid receptor blockade by eplerenone on echocardiographic abnormalities am… Pending

2024-515860-29-00 Phase III 1 country CHRU De Nancy
Comparative study of eplerenone-based treatment strategy versus irbesartan-based blood pressure lowering in obese hypertensive patients (HEB… Pending

2024-519749-31-00 Phase IV 1 country Institute For Study Research Education And Therapy Of Vascular Heart Brain And K…
Pharmacological optimization in prevention in Heart Failure: A Sex-gap? Recruiting

2025-520660-18-00 Phase IV 1 country Policlinico San Donato S.p.A.
Double-blind Placebo-Controlled Randomized Clinical Trial of Mineralocorticoid Receptor Blockade With Eplerenone After Renal Transplantation… Recruiting

2024-517408-12-00 Phase III 1 country CHRU De Nancy
Optimal medical treatment of difficult-to-treat hypertension. Recruiting

2024-517628-20-00 Phase III/IV 1 country Narodowy Instytut Kardiologii Stefana Kardynala Wyszynskiego Panstwowy Instytut …
CROWD-ASPECT Recruiting

2022-502239-20-00 Phase IV 1 country Bispebjerg Hospital
Withdrawal of Pharmacological Treatment in Patients Responding to Cardiac Resynchronization Therapy: (REMOVE) Ended

2023-504946-70-00 Phase IV 1 country Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia
The Effect of Eplerenone on the Evolution of Vasculopathy in Renal Transplant Patients. (EVATRAN) Ended

2024-513808-34-00 Phase III 1 country CHRU De Nancy

Showing 1–8 of 8 trials

← All drugs A–Z